Depressive Disorder: all 4,847 studies

Page 9 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.

• Cost- Effectiveness and Quality of Life Assessment in Major Depression DisorderCompletedNCT02901249Phase 4Results posted
• Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid AllopregnanoloneCompletedNCT02900092Not applicableResults posted
• The UTHealth Ketamine ProjectTerminatedNCT02882711Phase 2Results posted
• 5 Alpha Reductase Inhibitors And The Risk Of Suicide And DepressionCompletedNCT02876757Results posted
• Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of AgeTerminatedNCT02871297Phase 3Results posted
• COMRADE: Collaborative Care Management for Distress and Depression in Rural DiabetesCompletedNCT02863523Not applicableResults posted
• Integrated Smoking Cessation Treatment for Smokers With Serious Mental IllnessCompletedNCT02845440Not applicableResults posted
• Online Peer Networked Collaborative Learning for Managing Depressive SymptomsCompletedNCT02841787Not applicableResults posted
• NeoSync TMS Treatment for Bipolar I DepressionTerminatedNCT02839798Phase 2Results posted
• Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)CompletedNCT02816138Phase 4Results posted
• Lifestyle Intervention for Young Adults With Serious Mental IllnessCompletedNCT02815813Not applicableResults posted
• PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphYCompletedNCT02811302Not applicableResults posted
• Treatment of Depression With Connectivity Guided Robotically Delivered rTMSTerminatedNCT02802293Not applicableResults posted
• IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for DepressionCompletedNCT02801877Not applicableResults posted
• A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionCompletedNCT02782104Phase 3Results posted
• Increasing Physical Activity Among Breast Cancer Survivors With DepressionCompletedNCT02781051Not applicableResults posted
• Internet-guided Cognitive Behavioural Therapy to Improve Depression Patients With Cardiovascular DiseaseCompletedNCT02778074Not applicableResults posted
• The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum DepressionCompletedNCT02769858Not applicableResults posted
• Depression, Obesity and Inflammatory MarkersCompletedNCT02765100Not applicableResults posted
• Assessment of a Oral Endotracheal Tube Fastener on Patients Intubated With Oral Endotracheal TubesTerminatedNCT02760927Not applicableResults posted
• Nitrous TRD Bipolar DepressionTerminatedNCT02757521Early Phase 1Results posted
• The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive DisorderCompletedNCT02749721Phase 4Results posted
• A Study of L-DOPA for Depression and Slowing in Older AdultsCompletedNCT02744391Phase 4Results posted
• The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless AdultsCompletedNCT02732561Not applicableResults posted
• Supportive and Supportive-Expressive Treatment for DepressionCompletedNCT02728557Not applicableResults posted
• Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine SystemCompletedNCT02722967Phase 2Results posted
• Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDDCompletedNCT02720198Phase 3Results posted
• Implementing a Blended Care Model That Integrates Mental Healthcare and Primary Care Using Telemedicine and Care Management for Patients With Depression or Alcohol Use Disorder in Small Primary Care ClinicsCompletedNCT02713217Results posted
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)CompletedNCT02709746Phase 3Results posted
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)CompletedNCT02709655Phase 3Results posted
• Effects of Amygdala Neurofeedback on Depressive SymptomsTerminatedNCT02709161Not applicableResults posted
• LFMS: Initial Trial in Geriatric Bipolar DepressionTerminatedNCT02707276Not applicableResults posted
• Investigating Transcranial Ultrasound as a Potential Intervention for DepressionCompletedNCT02685488Not applicableResults posted
• EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early PregnancyCompletedNCT02676882Not applicableResults posted
• Study of Neural Responses Induced by Antidepressant EffectsCompletedNCT02674529Phase 2/3Results posted
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I DepressionCompletedNCT02670551Phase 3Results posted
• The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using ActigraphyCompletedNCT02669082Phase 4Results posted
• Tapering Off AntidepressantsTerminatedNCT02661828Not applicableResults posted
• Ketamine for Relapse Prevention in Recurrent Depressive DisorderTerminatedNCT02661061Phase 1Results posted
• Tocilizumab Augmentation in Treatment-Refractory Major Depressive DisorderTerminatedNCT02660528Phase 2Results posted
• Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication TrialCompletedNCT02646449Phase 2Results posted
• An Open Label Trial of TMS Therapy for Bipolar DepressionCompletedNCT02640950Not applicableResults posted
• Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDDCompletedNCT02634177Not applicableResults posted
• SSRI Effects on Depression and Immunity in HIV/AIDSCompletedNCT02620150Phase 4Results posted
• Repetitive Transcranial Magnetic Stimulation for Adolescent Depression: Efficacy, Predictive Biomarkers, and MechanismsCompletedNCT02611206Not applicableResults posted
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar DepressionCompletedNCT02600507Phase 3Results posted
• Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed AdolescentsCompletedNCT02586688Not applicableResults posted
• Ketamine Infusion for Adolescent Depression and AnxietyCompletedNCT02579928Phase 4Results posted
• Adjunctive Treatment of Major Depression Utilizing Auricular AcupunctureCompletedNCT02579343Not applicableResults posted
• TAK-653 Escalating Single and Multiple Dose Study in Healthy ParticipantsCompletedNCT02561156Phase 1Results posted
• Ketamine for Treatment Resistant Late-Life DepressionCompletedNCT02556606Phase 3Results posted
• Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized ApproachCompletedNCT02553915Phase 2/3Results posted
• Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQCompletedNCT02548949Results posted
• Ketamine for Depression: An MRI StudyCompletedNCT02544607Phase 4Results posted
• Sleep-Disordered Breathing and PAP in Perinatal DepressionCompletedNCT02507297Not applicableResults posted
• Study of Ibuprofen Effects on Brain FunctionCompletedNCT02507219Phase 2/3Results posted
• Preventing Postpartum Depression With Intranasal OxytocinCompletedNCT02505984Phase 2Results posted
• An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious DistressCompletedNCT02498392Phase 2Results posted
• Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and AnxietyCompletedNCT02497755Not applicableResults posted
• A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionCompletedNCT02497287Phase 3Results posted
• A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionCompletedNCT02493868Phase 3Results posted
• Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive DisorderCompletedNCT02484456Phase 2Results posted
• Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)CompletedNCT02475954Not applicableResults posted
• The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDDCompletedNCT02473783Phase 2Results posted
• An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive DisorderCompletedNCT02473289Phase 2Results posted
• Trial of Levomilnacipran in Geriatric DepressionCompletedNCT02466958Phase 4Results posted
• Role of Magnesium Supplementation in the Treatment of DepressionCompletedNCT02466087Phase 2/3Results posted
• Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use DisorderCompletedNCT02461927Phase 1/2Results posted
• Brain Connectivity and Response to Tai Chi in Geriatric DepressionCompletedNCT02460666Not applicableResults posted
• eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed PatientsCompletedNCT02458690Phase 2Results posted
• Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)CompletedNCT02452892Not applicableResults posted
• A Study of Vilazodone in Pediatric Patients With Major Depressive DisorderCompletedNCT02436239Phase 3Results posted
• Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive DisorderCompletedNCT02431806Phase 3Results posted
• Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive SymptomsTerminatedNCT02422303Not applicableResults posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionCompletedNCT02422186Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedNCT02418585Phase 3Results posted
• miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment OutcomeCompletedNCT02418195Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedNCT02417064Phase 3Results posted
• Influenza Challenge in Mood DisordersTerminatedNCT02415166Not applicableResults posted
• Ketamine for Depression Relapse Prevention Following ECTCompletedNCT02414932Early Phase 1Results posted
• A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and ExerciseCompletedNCT02407704Phase 4Results posted
• Supported Employment in Patient Aligned Care TeamsCompletedNCT02400736Not applicableResults posted
• Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant TreatmentCompletedNCT02400346Phase 3Results posted
• A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive DisorderCompletedNCT02395978Phase 2Results posted
• A Phase 3 Study of Lu AA21004 in Patients With Major Depressive DisorderCompletedNCT02389816Phase 3Results posted
• Stress and Inflammation in Late-Life DepressionCompletedNCT02389465Phase 4Results posted
• Behavioral Activation and Varenicline for Smoking Cessation in Depressed SmokersCompletedNCT02378714Phase 4Results posted
• Improving Therapeutic Learning in Depression: Proof of ConceptCompletedNCT02376257Phase 2Results posted
• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)CompletedNCT02372799Phase 3Results posted
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)CompletedNCT02371980Phase 4Results posted
• Comparing Effectiveness of Treating Depression With & Without Comorbidity to Improve Fetal HealthCompletedNCT02371356Results posted
• Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)CompletedNCT02367521Phase 2/3Results posted
• 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II DepressionCompletedNCT02363738Phase 2Results posted
• Efficacy of Repeated Ketamine Infusions for Treatment-resistant DepressionCompletedNCT02360280Phase 2Results posted
• A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}CompletedNCT02358343Phase 3Results posted
• 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in FemalesCompletedNCT02356107Phase 4Results posted
• Social Media Intervention for Postpartum DepressionCompletedNCT02355067Not applicableResults posted
• Transcranial Alternating Current Stimulation for Major Depressive DisorderCompletedNCT02339285Not applicableResults posted
• Connectivity Affecting the Antidepressant REsponse StudyCompletedNCT02332291Phase 4Results posted
• Text-Message-Based Depression Prevention for High-Risk Youth in the EDCompletedNCT02332239Not applicableResults posted

← Depressive Disorder overview